PECULIARITIES OF THE NEURAL NETWORK INFORMATIVITY OF IMMUNOLOGICAL PARAMETERS IN PATIENTS WITH ACROMEGALY
暂无分享,去创建一个
[1] M. Puig Domingo. Treatment of acromegaly in the era of personalized and predictive medicine , 2015, Clinical endocrinology.
[2] C. Ziegler,et al. Features of cell death, mitochondrial activation and caspase dependence of rabbit anti-T-lymphocyte globulin signaling in lymphoblastic Jurkat cells are distinct from classical apoptosis signaling of CD95 , 2016, Leukemia & lymphoma.
[3] P. Chanson,et al. Consensus statement: medical management of acromegaly. , 2005, European journal of endocrinology.
[4] C. Poiană,et al. Current therapies and mortality in acromegaly , 2015, Journal of medicine and life.
[5] P. Marzullo,et al. Lymphocyte subset pattern in acromegaly , 2002, Journal of endocrinological investigation.
[6] Min-jung Park,et al. Murine Mesenchymal Stem Cells Suppress T Lymphocyte Activation Through IL-2 Receptor α (CD25) Cleavage by Producing Matrix Metalloproteinases , 2011, Stem Cell Reviews and Reports.
[7] R. Ajisaka,et al. Effect of 6-day intense Kendo training on lymphocyte counts and its expression of CD95 , 2009, European Journal of Applied Physiology.
[8] C. Grevelding,et al. Effect of cytotoxic T-lymphocyte-associated protein 4 on CD4(+)CD25(+) regulatory T cells in murine schistosomiasis japonica. , 2014, Experimental parasitology.